| Table 2. Comparison of patients' characteristics at the baseline and after 3-months of treatment with orlistat | |||
| Parameters | Baseline | After treatment | p-value* |
| BMI (kg/m2) (Mean) | 32.69±0.94 | 30.62±0.78 | <0.001 |
| Waist (cm) (Mean) | 114.15±10.06 | 111.05±11.67 | <0.001 |
| Testosterone (ng/ml) (Mean) | 0.80±0.23 | 0.63±0.22 | <0.001 |
| 17α-OH Progesterone (ng/ml) (Mean) | 1.13± 0.11 | 1.00±1.1 | NS |
| DHEA-S (µg/ml) (Mean) | 2.17±0.29 | 2.12±0.29 | NS |
| SHBG (nmol/l) (Mean) | 24.77±3.3 | 30.59±6.5 | NS |
| LH (mIU/ml) (Mean) | 12.94±1.7 | 11.36±1.06 | NS |
| FSH (mIU/ml) (Mean) | 5.53±0.51 | 8.77±3.39 | NS |
| NS: Not Significant | |||